Malaria DNA vaccine (Naval Medical Research Center)

N/A

Report date: 2022/09/05 10:34:08

Base Information

Drug NameMalaria DNA vaccine (Naval Medical Research Center)
Drug Alias NameMalaria DNA vaccine VCL-2510疟疾基因疫苗 - Naval Medical Research Center/Vical疟疾DNA疫苗 - Naval Medical Research Center/VicalMuStDO-5VCL-2510
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMalaria, Falciparum
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGhana
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNaval Medical Research Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsMalaria, Falciparum

Other Information

ATC CodeN/A
Related LinksN/A